The aim of this study is to assess physician and patient satisfaction with ofatumumab using data collected from physicians and their multiple sclerosis (MS) patients in real-world clinical practice across the United Kingdom (UK), France, Germany, Italy, Spain, China, Japan, and Brazil.
Study Type
OBSERVATIONAL
Enrollment
261
Novartis
Basel, Switzerland
Number and Percentage of Patients by Patient-reported Level of Satisfaction With Current MS Treatment
Patient's level of satisfaction with current treatment categorized as follows: * Completely dissatisfied * Moderately dissatisfied * Neither dissatisfied nor satisfied * Moderately satisfied * Completely satisfied * Not on any current treatment for MS
Time frame: 1 Day
Number and Percentage of Patients by Patient-reported MS Status With Their Current Medication Compared to Previous Medication
MS status, as reported by the patient, categorized as follows: * Very much better * Much better * A little better * No change * A little worse * Much worse * Very much worse * Don't know * No previous medication taken for MS
Time frame: 1 Day
Number and Percentage of Patients by Physician-reported Patient Response to Current MS Treatment
How well the patient is responding to current treatment rated by the physician from 1 (very poorly) to 5 (very well).
Time frame: 1 Day
Number and Percentage of Patients by Physician-reported Level of Satisfaction With the Patient's Current MS Treatment
Physician's level of satisfaction with patient's current treatment categorized as follows: * Completely dissatisfied * Moderately dissatisfied * Neither dissatisfied nor satisfied * Moderately satisfied * Satisfied * Completely satisfied
Time frame: 1 Day
Number and Percentage of Patients Adherent to Current MS Treatment as Reported by the Physician
Adherence, as reported by the physician, categorized as follows: * Completely adherent * Mostly adherent * Somewhat adherent * A little adherent * Not at all adherent * Too early in patient's regimen to tell * Don't know
Time frame: 1 Day
Number and Percentage of Patients by Physician-reported Change in Patient Condition Since Initiation of Current MS Treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Change in condition, as reported by the physician, categorized as follows: * Very much improved * Much improved * A little bit improved * No change * A little bit worse * Much worse * Very much worse
Time frame: 1 Day
Number and Percentage of Patients by Factors That Influence How the Patient Rates Current Medication Compared to Previous Medication
Factors influencing how patients rate medication include: * Frequency of relapses * Impact on symptoms during relapses * MS progression * Convenience (impact on daily routine) * Side effects * Route of administration * Frequency of administration * Impact on quality of life (e.g. liveliness, social functioning, perceived wellbeing) * No change / No previous medication for MS taken * Don't know
Time frame: 1 Day
Number and Percentage of Patients by Physician-reported Reason for Current MS Treatment Choice
Time frame: 1 Day
Number and Percentage of Patients by Physician-reported Top 5 Reasons for Current MS Treatment Choice
Time frame: 1 Day
Number and Percentage of Patients by Physician-reported Main Areas of Improvement for the Patient's Current MS Treatment
Time frame: 1 Day